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2002.—T-type calcium channels may be involved in the main-
tenance of myogenic tone. We tested their role in isolated rat
cremaster arterioles obtained after CO2 anesthesia and de-
capitation. Total RNA was analyzed by RT-PCR and South-
ern blotting for calcium channel expression. We observed
expression of voltage-operated calcium (CaV) channels
CaV3.1 (T-type), CaV3.2 (T-type), and CaV1.2 (L-type) in
cremaster arterioles (n  3 rats). Amplification products
were observed only in the presence of reverse transcriptase
and cDNA. Concentration-response curves of the relatively
specific L-type blocker verapamil and the relatively specific
T-type blockers mibefradil and nickel were made on cannu-
lated vessels with either myogenic tone (75 mmHg) or a
similar level of constriction induced by 30 mM K at 35
mmHg. Mibefradil and nickel were, respectively, 162-fold
and 300-fold more potent in inhibiting myogenic tone com-
pared with K-induced constriction [log(IC50, M): mibefradil,
basal 7.3  0.2 (n  9) and K 5.1  0.1 (n  5); nickel,
basal 4.1  0.2 (n  5) and K 1.6  0.5 (n  5); means 
SE]. Verapamil had a 17-fold more potent effect [log(IC50, M):
basal 6.6  0.1 (n  5); K 5.4  0.3 (n  4); all log(IC50)
P  0.05, basal vs. K]. These data suggest that T-type
calcium channels are expressed and involved in maintenance
of myogenic tone in rat cremaster muscle arterioles.
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IN RESPONSE TO PRESSURE, arterioles and small resistance
arteries generally develop vasoconstriction in the ab-
sence of any extrinsic agonists. This myogenic tone
becomes more dominant in smaller vessels (4) and is
thought to play a key role in the local control of tissue
perfusion. The mechanisms responsible for myogenic
tone have been the subject of ongoing studies. It is now
well established that myogenic tone is independent of
the endothelium in most vascular beds examined (17),
even though endothelial products are the primary mod-
ulators of myogenic tone. This tone is associated with a
rather modest but necessary smooth muscle cell (SMC)
depolarization (28) and rise of intracellular calcium
(25, 31) in combination with a pressure-induced in-
crease in calcium sensitivity of the contractile fila-
ments (25).
Pharmacological evidence indicates that L-type volt-
age-operated calcium (CaV) channels are significantly
involved in pressure-induced calcium influx and tone
in several resistance vessels (5, 27). However, steady-
state open probability of these channels is quite low at
membrane potentials frequently found under basal
conditions [60 to 40 mV at physiological pressures
(5, 24)]. The activation range of the smooth muscle
L-type channel CaV1.2 may be shifted by regulation
(11), and only a small calcium influx might be needed
to maintain an elevated intracellular concentration
(19). Alternatively, low-voltage-activated T-type cal-
cium channels may be involved in the calcium influx
associated with myogenic tone. These channels acti-
vate at more negative potentials and may only par-
tially inactivate at membrane potentials associated
with myogenic tone. Two recent studies have indeed
shown that mibefradil, a T-type channel antagonist,
inhibits myogenic tone in rat cerebral and cremaster
vessels at concentrations (IC50 70 and 220 nM) that
have been claimed to be specific for T-type over L-type
calcium channels (15, 22).
Expression of recently cloned calcium channels in
heterologous cell systems has established the existence
of three pore-forming channel subunits with T-type
current characteristics (activation at low voltages and
rapid inactivation, sensitivity to mibefradil and nickel):
CaV3.1, CaV3.2, and CaV3.3 (previously known as 1G,
1H, and 1I) (6, 20). mRNA for CaV3.1 and CaV3.2 and
functional involvement in contraction have now been
demonstrated in renal afferent and juxtamedullary
efferent arterioles (10). mRNA for T-type calcium chan-
nels was also found in rat mesenteric arterioles of 30Address for reprint requests and other correspondence: E. Van-
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m in diameter (8), whereas the L-type channel CaV1.2
was absent, and these arterioles also did not constrict
to high potassium.
The above information supports a widespread distribu-
tion of T-type channel expression in vascular resistance
segments and a role for T-type calcium channels in arte-
riolar function. The purpose of this paper was to investi-
gate T-type channel expression in skeletal muscle resis-
tance vessels and to further explore whether T-type
channels are involved in the maintenance of myogenic
tone. To address these issues, rat cremaster muscle arte-
rioles were cannulated in vitro, and the sensitivity of
myogenic tone to pharmacological antagonists of L- and
T-type channels was elucidated. Sensitivity to antago-
nists was compared in two situations with different mem-
brane potentials: at physiological perfusion pressure and
at a low perfusion pressure where the same level of tone
was achieved by the addition of potassium to depolarize
the membrane potential.
METHODS
Isolation of resistance arteries. Male Wistar rats weighing
250–300 g were briefly anesthetized by CO2 gas and decap-
itated. The left and right cremaster muscles were carefully
isolated, suspended in buffer [containing (in mmol/l) 130
NaCl, 5 KCl, 2 CaCl2, 10 D-glucose, 20 sucrose, and 10
HEPES; pH 7.4] and mounted in dissection chambers for
isolation of vessels at 4°C. For molecular biology, first- and
second-order vessel segments with a total length of 1 cm
were isolated from each cremaster. For pharmacology on
cannulated vessels, unbranched segments of first-order arte-
rioles were isolated of 3 mm in length.
RNA isolation, RT-PCR, and Southern blotting. First- and
second-order arterioles were cut in 400-m pieces and
directly added to guanidinium-thiocyanate (4 mol/l) as pre-
viously described (1, 2). For homogenization, the fragments
were repeatedly triturated through syringes with decreasing
dimensions ending with 25 gauge. Yeast tRNA (12 g) was
added as a carrier. Total RNA was extracted by phenol-
chloroform extraction, precipitated with isopropanol, and re-
peatedly washed with 70% ethanol (2). RNA pellets were
suspended in diethyl pyrocarbonate-treated water and used
for cDNA synthesis as previously described in detail (1). RNA
corresponding to 1 mm of vessel length was used for cDNA
synthesis.
PCRs were performed with 18-mer DNA oligonucleotides
(Invitrogen) for rat T- and L-type CaV channels and 	-actin
as previously described (10). PCR was performed for 32 cycles
(Mastercycler, Eppendorf). For a negative control, reverse
transcription of total RNA was performed in the absence of
reverse transcriptase and then amplified by PCR, and, in
separate tubes, water was added instead of cDNA in PCR.
For southern blotting, PCR products were separated by aga-
rose gel electrophoresis and blotted to Zeta Probe GT mem-
branes (Bio-Rad) using standard capillary blotting proce-
dures as previously described (1). Hybridization was allowed
overnight to a specific probe in vitro labeled with [-32P]-
dCTP; all procedures were according to Sambrook et al. (23).
Autoradiography was performed for 2–4 h on Kodak Biomax
MS film.
Pharmacological studies. Isolated cremaster muscle arte-
rioles were cannulated on two glass micropipettes using
previously reported techniques (25). Vessels were pressur-
ized to 75 mmHg at 34°C, the in vivo temperature of the
cremaster muscle, and allowed to develop myogenic tone.
Cumulative concentration-response curves were then made
for the effect of one of three calcium channel blockers on tone:
verapamil, an L-type calcium channel blocker, the analog
mibefradil, which is relatively selective for T-type channels,
and nickel, which also relatively selectively blocks T-type
channels. Only one blocker was used for each vessel. In
separate experiments, the effect of these blockers was tested
on vessels kept at 35 mmHg, resulting in a lack of myogenic
tone, after the induction of preconstriction by 30 mM K. On
the basis of the potassium equilibrium potential, this concen-
tration was estimated to result in a depolarization to at least
35 mV, where T-type but not L-type channels are inacti-
vated.
Data analysis and statistics. IC50 values were determined
for each individual concentration-response curve using non-
linear curve fitting with variable Hill slope (GraphPad) and
subsequently averaged over the group. Unpaired t-tests were
used for the comparison of the log(IC50) values on myogenic
tone and potassium-induced constriction. P  0.05 was con-
sidered statistically significant.
RESULTS
Expression of 1-units of calcium channels. RNA was
extracted from cremaster muscle arterioles of three
rats and analyzed along with RNA obtained from an
aortic cell line (A7r5) and the rat cerebral cortex, which
Fig. 1. A: RT-PCR amplification products for the T-type
voltage-operated calcium (CaV) channels CaV3.1 and
CaV3.2, the L-type channel CaV1.2, and 	-actin (	-Act).
B: results of Southern blotting of these products. Lanes
from left to right: size marker (
X174 DNA/HaeIII
markers), cDNA amplified from cremaster muscle arte-
rioles from 3 separate rats (Crem), negative control
[absence of reverse transcriptase (RT)], cDNA ampli-
fied from an aortic smooth muscle cell line (A7r5),
positive control where cDNA from the rat cerebral cor-
tex was amplified (Cer cortex), and negative control
where carrier tRNA was amplified (tRNA).
H2240 T-TYPE CALCIUM CHANNELS AND MYOGENIC TONE
AJP-Heart Circ Physiol • VOL 283 • DECEMBER 2002 • www.ajpheart.org
 by 10.220.33.4 on January 15, 2017
http://ajpheart.physiology.org/
D
ow
nloaded from
 
served as a positive control. As can be seen in Fig. 1A,
amplification products for T-type channels CaV3.1 and
CaV3.2 were detected in all three cremaster vessel
preparations by RT-PCR amplification for 32 cycles.
Southern blotting and hybridization further corrobo-
rated the identity of the amplification products as
being CaV3.1 and CaV3.2 cDNAs (Fig. 1B). In contrast,
L-type channel CaV1.2 mRNA was not found in one of
the cremaster vessels and was at the limit of detection
by ethidium bromide staining in both other prepara-
tions. However, the increased sensitivity provided by
the Southern blot assured expression and identity of
CaV1.2 in these preparations (Fig. 1B). Expression of
all three subunit mRNAs was also detected in the rat
aortic SMC line A7r5 and in RNA samples isolated
from the rat cerebral cortex using 50 ng total RNA as
template for RT-PCR. Amplification products were
only obtained in the presence of reverse transcriptase
and cDNA in the RT-PCR, confirming the mRNA origin
of the amplification products. Reverse transcription of
carrier yeast tRNA followed by PCR for each subunit
did also not result in detectable amplification products
(Fig. 1, tRNA lane).
Pharmacological studies. Nineteen vessels were
studied in the myogenic tone group, having an average
passive inner diameter of 145  3 m at 75 mmHg.
When maintained at this pressure, the vessels devel-
oped myogenic tone, resulting in a reduction of the
normalized inner diameter to 0.57  0.03 (mean  SE,
n  19). Myogenic tone was sensitive to verapamil,
mibefradil, and nickel; concentration-response curves
are indicated in Figs. 2–4. Log(IC50) values are indi-
cated in Table 1. Fourteen slightly smaller vessels (pas-
sive inner diameter at 75 mmHg: 134 3 m, P 0.05)
were kept at 35 mmHg. The vessels remained passive
at this diameter, probably due to myogenic inhibition
of tone. A stable level of preconstriction was induced by
30 mM K, resulting in a reduction of the normalized
diameter to the same level as in the previous series:
0.54  0.03 (P  not significant, basal versus K). All
three calcium channel blockers were able to inhibit the
potassium-induced tone, as indicated by the concentra-
tion-response curves in Figs. 2–4 and the IC50 values
in Table 1. A comparison of the inhibition of basal
versus potassium-induced tone shows marked differ-
ences: both mibefradil and nickel were very potent
inhibitors of basal but not of potassium-induced tone.
Thus a 162-fold difference in IC50 was found for mibe-
fradil, whereas the IC50 for nickel was 300-fold lower
on myogenic tone compared with potassium-induced
constriction. Verapamil, an L-type calcium channel
blocker, 17-fold more potently blocked myogenic tone
compared with potassium-induced tone (see Table 1).
DISCUSSION
This study shows that T-type calcium channel sub-
units CaV3.1 and CaV3.2 are expressed in rat cremas-
ter muscle arterioles and that mibefradil and nickel
were far more potent inhibitors of myogenic tone com-
Fig. 2. Inhibition of myogenic tone at 75 mmHg and potassium-induced
constriction (30 mM at 35 mmHg) by verapamil. Error bars are SE.
Fig. 3. Inhibition of myogenic tone at 75 mmHg and potassium-
induced constriction (30 mM at 35 mmHg) by mibefradil.
Fig. 4. Inhibition of myogenic tone at 75 mmHg and potassium-
induced constriction (30 mM at 35 mmHg) by nickel.
Table 1. Effect of calcium channel blockers on
myogenic tone and K-induced constriction
Calcium
Channel
Blocker
Log(IC50, M)
Significance
Myogenic tone
(75 mmHg)
K (30 mM)
constriction
(35 mmHg)
Verapamil 6.630.16 (n5) 5.400.33 (n4) 0.01
Mibefradil 7.310.19 (n9) 5.100.11 (n5) 0.00001
Nickel 4.080.18 (n5) 1.600.49 (n5) 0.001
Results are means  SE; n  no. of rats. Values are unitless log
(IC50), where IC50 is expressed in molars. Significance was measured
by unpaired t-tests.
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pared with potassium-induced tone. While we appreci-
ate that both blockers may also affect L-type calcium
channels, the two decades higher potency on myogenic
tone compared with potassium-induced constriction
suggests specific actions in the current study. To-
gether, these data point at a role for T-type calcium
channels in the development and maintenance of myo-
genic tone.
Care should be taken in relating the expression of
CaV3.1 and CaV3.2 at the messenger level to their
possible role in cell function, because the applied RT-
PCR was not quantitative and because messenger and
protein levels may well diverge. Also, the RT-PCR was
performed on the whole vascular wall. While there is
no evidence for expression of voltage-dependent cal-
cium channels in endothelial cells, and while it seems
highly unlikely that the perivascular nerve endings
contain any mRNA, we cannot fully exclude the possi-
bility that part of the messenger signal we found for
the T-type channels originated from other cells than
SMCs. Immunohistochemical evidence could further
substantiate expression and localization of these chan-
nels, but this awaits the further development of anti-
bodies. We attempted to obtain electrophysiological
evidence for these channels in SMCs isolated from
cremaster arterioles. However, in our hands, the diges-
tion protocols, which included papain, resulted in cells
that had neither L- nor T-type currents and also did
not contract to high potassium concentrations. The
single study we are aware of that did successfully
measure calcium currents in these specific cells (29)
was not aimed at discriminating between both chan-
nels. In that study, using holding potentials of 80
mV, no clear calcium or barium currents were observed
below 50 and 20 mV, respectively, arguing against
functional involvement of T-type channels under those
conditions. Further patch-clamp experiments will be
required here. However, T-type calcium currents have
been demonstrated in vascular smooth muscle cells of
other sources (7, 21).
In our study, nickel blocked myogenic tone with a
threshold concentration of 10 M and an IC50 of 0.1
mM. These values are very similar to the threshold and
IC50 reported for inhibition of peak current in ex-
pressed CaV3.1 channels, whereas CaV3.2 channels
had a higher sensitivity for nickel (16). Nickel also
blocks expressed CaV1.2 currents, but at a much
higher concentration [100 M (30)]. Thus our data
indicate that specifically CaV3.1 could be involved in
the maintenance of myogenic tone, in accordance with
the observed expression of this channel. The role of
CaV3.2, which we also found to be expressed, remains
to be elucidated.
Mibefradil has been put forward (3, 18) and chal-
lenged (22) as a relatively selective T-type calcium
channel blocker. Mibefradil inhibited Ba2 current
through expressed CaV3.1 at a holding potential of60
mV with an IC50 at 0.12 M (12), whereas the effects
using calcium as the charge carrier were similar (14).
Two recent studies addressed the effects of mibefradil
on myogenic tone. Lam et al. (15) found mibefradil to
inhibit myogenic tone at 60 mmHg with an IC50 of 70
nM in rat middle cerebral arteries. Potocnik et al. (22)
studied the effects of mibefradil on rat cremaster arte-
rioles and observed inhibition of myogenic tone at 70
mmHg with an IC50 of 0.22 M. The current study on
the same vessel type and perfusion at 75 mmHg found
a similar IC50 for mibefradil at 0.17 M. Thus these
studies find effects of mibefradil on myogenic tone that
are, based on the electrophysiology of the cloned chan-
nel, consistent with an inhibition of CaV3.1. However,
Potocnik et al. (22) argued that the effects of mibefradil
on myogenic tone may not be carried through T-type
calcium channels. In that study (22), mibefradil up to
10 M did not lower the intracellular calcium concen-
tration and failed to prevent the rise in calcium upon
pressure steps and application of high potassium, even
though the contractile response was inhibited. The
authors suggested that mibefradil could have intracel-
lular effects on calcium sensitivity rather than block-
ade of T-type calcium channels.
The clear difference in effects of mibefradil and
nickel on pressure-induced versus potassium-induced
tone could relate to the membrane potential. Alterna-
tively, pressurization might directly affect the opening
of the T-type calcium channels. Also, we cannot fully
rule out effects of these blockers on the nonselective
cation channels recently shown to be involved in pres-
sure-induced depolarization (26). An inhibitory effect
of both blockers on nonselective cation conductance has
recently been demonstrated on visceral SMCs (13).
Whether the difference in potency of verapamil on
myogenic versus potassium-induced tone reflects direct
modulation of the L-type calcium channels or other
effects of this blocker remains to be established.
Whereas in our study the low potency of nickel and
mibefradil on K-induced constriction is in accordance
with the involvement of L-type calcium channels, other
studies do indicate a higher sensitivity of depolar-
ization-induced arteriolar constriction to mibefradil
and/or nickel (10, 22) also in the cremaster arterioles
that we studied (22). The protocols, however, were
different: we first established a stable potassium-in-
duced contraction and then performed a cumulative
concentration-response series of the blockers, whereas
others tested the effect of a sudden switch to high
potassium in the presence of varying concentrations of
the blockers. Comparison of the above studies suggests
that potassium-induced contraction could be initiated
by calcium influx through T-type channels, whereas its
maintenance requires L-type channels. Maintenance of
myogenic tone, however, was shown here to depend on
T-type calcium channels.
Gustafsson et al. (8) studied the contribution of L-
and T-type calcium channels in local and conducted
vasoconstriction of rat mesenteric arterioles of30 m
in diameter. These authors found the constriction to
topical norepinephrine and current stimulation to be
fully insensitive to the L-type channel blockers nifedi-
pine and nimodipine. Also, the L-type channel CaV1.2
was not expressed, and the arterioles did not contract
to high concentrations of potassium. In contrast,
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CaV3.1 and CaV3.2 were expressed, and nickel and
mibefradil suppressed the local and conducted con-
strictions to norepinephrine and current injection. Pos-
sible side effects of the blockers on L-type currents can
be excluded here because those channels were not
expressed. Hansen et al. (9, 10) found expression of
CaV1.2, CaV3.1, CaV3.2, and the P-/Q-type CaV2.1 in
rat afferent arterioles. Each of the calcium channel
blockers calciseptine (specific for L-type channels),
-agatoxin IVA (P-/Q-type blocker), mibefradil, and
nickel fully inhibited contraction of cannulated rabbit
afferent arterioles to 100 mM K at concentrations
believed to reflect specific actions. Interestingly, T- and
L-type calcium channels were not found in cortical
efferent arterioles. Those studies point at a highly
regulated differential distribution of CaV channels
along the renal vasculature and at the significance of
T-type calcium channels. The current study and those
of Hansen et al. (9, 10) suggest that a cooperative
action of multiple types of calcium channels is required
for the maintenance of constriction. It is not clear how
this correlates with a simple parallel arrangement of
the channels in the cell membrane. Intracellular cal-
cium gradients or heterogeneity within the SMC pop-
ulation could provide explanations.
In conclusion, T-type calcium channels were ex-
pressed at the messenger level in rat cremaster arte-
rioles. Pharmacological evidence supports their contri-
bution to myogenic tone.
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